Skip to main content
Equibles
OCEA logo

OCEA · Ocean Biomedical, Inc.

Track OCEA — free

Use OCEA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OCEA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.01 -0.01 (-52.20%) At close · Apr 24
Rebalance outlook locked
Going-concern doubt — flagged May 15, 2025

Substantial doubt about the company's ability to continue as a going concern.

“These events and conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued.”
View the 10-Q filed May 15, 2025
Market Cap
$348,547
Shares
232.37M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.01 Open$0.01 Day$0.01–0.02 52W close$0.01–1.76 Avg vol 30d68.6M Short int65K · 0.0% float · 1.0d Short vol11% DataFeb 2023–Apr 2025 Filing10-Q · May 15

Up next

Latest filing: 10-Q
filed May 15, 2025

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$30.72M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+232.9%
Year over year · more shares
Price change (1Y)
-99.3%
Trailing year
Short interest
—
Latest settlement
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 17.8 · elevated Equity put/call 0.60
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −98%
below
Price vs 50-day avg −87%
below
RSI (14) 21
oversold
MACD trend Positive
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −88%
trailing
6-month return −99%
trailing
YTD return −98%
this year
Relative strength −93%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Flat
0% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.03% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 3-yr low, contrarian setup
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 142%
annualized · 1-yr
Max drawdown −99%
past year
ATR 133.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−98% Bearish
Price vs 50-day avg
−87% Bearish
RSI (14)
21 Neutral
MACD trend
Positive Bullish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
No clear signal
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Flat
0% holders QoQ
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.03% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
1 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $0 · 0% Range high $2
vs 200-day avg -98% vs 50-day avg -87%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
OCEA
Ocean Biomedical, Inc.
this stock
$348,547 — — — 0.0%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $132.08B +13.5% +46.2% 30.4 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
 $83.15B +2.8% +20.8% 20.0 2.5%
ARGX
Argenx SE
 $62.33B +17.0% — — 2.0%
CSLLY
Csl Ltd
 $58.10B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders
Holders
1
% held
0.0%
Net QoQ
0 sh
Top holder
FNY Investment Advisers,…
Held Float
View
Short & Settlement
Short Interest
Shares short
65.4K
Days to cover
1.0d
Change
0 sh
View
Short Volume
Short vol %
11%
As of
Aug 21, 2026
Short Total
View
Off-Exchange
Off-exchange %
63.5%
Week of
Apr 21, 2025
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-9.5M
EPS diluted
$-0.34
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 5, 2025
This year
0
View
Exempt Offerings
Offering
$27.0M
Filed
Jun 15, 2023
View

Performance

5D 20D 120D MTD YTD
OCEA -77.3% -88.3% -98.9% -81.9% -98.2%
SPY +4.0% -3.9% -6.0% -2.3% -6.7%
vs SPY -81.3% -84.4% -92.9% -79.6% -91.5%
Key facts CIK 1869974 CUSIP 67644C104 Visit website